Pediatrix Medical Group, Inc. (NYSE:MD) Stock Has Consensus Price Target of $26.60 According to Analysts

Shares of Pediatrix Medical Group, Inc. (NYSE:MD) have been given a consensus recommendation of “Hold” by the six brokerages that are presently covering the firm, Marketbeat.com reports. Five research analysts have rated the stock with a hold recommendation and one has given a buy recommendation to the company. The average twelve-month price objective among analysts that have issued ratings on the stock in the last year is $26.60.

Several research analysts recently issued reports on MD shares. Deutsche Bank Aktiengesellschaft reissued a “hold” rating and set a $25.00 price target on shares of Pediatrix Medical Group in a report on Wednesday, August 5th. Weiss Ratings upgraded shares of Pediatrix Medical Group from a “hold (c+)” rating to a “buy (b-)” rating in a research report on Wednesday, September 9th. Truist Financial upped their price objective on Pediatrix Medical Group from $23.00 to $28.00 and gave the company a “hold” rating in a research report on Tuesday, July 14th. Jefferies Financial Group downgraded shares of Pediatrix Medical Group from a “buy” rating to a “hold” rating and upped their price objective for the company from $27.00 to $28.00 in a research note on Wednesday, August 19th. Finally, UBS Group raised their price target on Pediatrix Medical Group from $25.00 to $28.00 and gave the stock a “neutral” rating in a research note on Thursday, August 6th.

Institutional Inflows and Outflows

A number of institutional investors have recently made changes to their positions in MD. Tidal Investments LLC boosted its holdings in Pediatrix Medical Group by 253.9% in the second quarter. Tidal Investments LLC now owns 616,048 shares of the company’s stock valued at $15,604,000 after purchasing an additional 441,959 shares during the last quarter. WINTON GROUP Ltd grew its stake in Pediatrix Medical Group by 8.9% during the 2nd quarter. WINTON GROUP Ltd now owns 57,413 shares of the company’s stock worth $1,454,000 after buying an additional 4,710 shares during the last quarter. Integrated Wealth Concepts LLC acquired a new position in shares of Pediatrix Medical Group during the second quarter worth approximately $53,000. Nykredit A S acquired a new position in shares of Pediatrix Medical Group during the second quarter worth approximately $35,000. Finally, Corient Private Wealth LP bought a new position in Pediatrix Medical Group in the 2nd quarter worth approximately $832,000. 97.71% of the stock is owned by institutional investors and hedge funds.

Pediatrix Medical Group Stock Performance

Shares of MD stock opened at $25.79 on Friday. The firm has a 50 day moving average of $26.40 and a two-hundred day moving average of $24.24. The company has a quick ratio of 1.32, a current ratio of 1.32 and a debt-to-equity ratio of 0.45. The stock has a market capitalization of $2.10 billion, a PE ratio of 12.34 and a beta of 0.61. Pediatrix Medical Group has a 52 week low of $15.69 and a 52 week high of $27.94.

Pediatrix Medical Group (NYSE:MD) last released its earnings results on Tuesday, August 4th. The company reported $0.63 earnings per share for the quarter, topping analysts’ consensus estimates of $0.59 by $0.04. The firm had revenue of $487.78 million for the quarter, compared to analyst estimates of $478.49 million. Pediatrix Medical Group had a net margin of 8.96% and a return on equity of 20.05%. The business’s quarterly revenue was up 4.1% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.53 earnings per share. On average, research analysts predict that Pediatrix Medical Group will post 2.17 EPS for the current fiscal year.

Pediatrix Medical Group Company Profile

Pediatrix Medical Group, Inc provides physician-led health care services to hospitals, health systems and patients across the United States. The company focuses on specialized care for women, infants and children, supporting patients in hospital-based and affiliated clinical settings.

Its services include neonatal and perinatal care, maternal-fetal medicine, pediatric cardiology and other pediatric subspecialties. Pediatrix physicians commonly practice in neonatal intensive care units, delivery rooms, pediatric emergency departments and other hospital departments, working with care teams to manage complex medical needs.

The company was founded in 1979 and operated for many years under the name MEDNAX, Inc It adopted the Pediatrix Medical Group name in 2023 as part of a broader effort to emphasize its pediatric, neonatal and maternal-fetal health care businesses.